In gastric cancer, succinylation modification of FBN1 leads to its accumulation, activates TGF-β1 and triggers the activation of the phosphoinositide 3-kinase (PI3K)/AKT signaling, thereby promoting tumor proliferation (Wang X. et al., 2022). Here, FBN1 is linked to neoplasm.